Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Reproductive Toxicology (Elmsford, N.Y.)
|
May 8, 2010
Risks associated with in utero and lactation exposure to selective serotonin reuptake inhibitors (SSRIs)
Maria Ellfolk, Heli Malm
Duodecim; Laaketieteellinen Aikakauskirja
|
December 1, 2017
Which drugs can be used during pregnancy?
Heli Malm, Maria Ellfolk
Duodecim; Laaketieteellinen Aikakauskirja
|
November 22, 2012
[Poisonings and their treatment during pregnancy]
Maria Ellfolk, Heli Malm
Biochemical and Biophysical Research Communications
|
May 13, 2006
Isolation and properties of the CYP2D25 promoter: transcriptional regulation by vitamin D3 metabolites
Maria Ellfolk, Maria Norlin, Kjell Wikvall
Biochemical and Biophysical Research Communications
|
April 21, 2007
Phenobarbital suppresses vitamin D3 25-hydroxylase expression: a potential new mechanism for drug-induced osteomalacia
Fardin Hosseinpour, Maria Ellfolk, Maria Norlin, et al.
Molecular Pharmacology
|
March 17, 2009
Regulation of human vitamin D(3) 25-hydroxylases in dermal fibroblasts and prostate cancer LNCaP cells
Maria Ellfolk, Maria Norlin, Katarina Gyllensten, et al.
Basic & Clinical Pharmacology & Toxicology
|
July 13, 2016
Drug-Mediated Gene Regulation of Vitamin D<sub>3</sub> Metabolism in Primary Human Dermal Fibroblasts
Maria Norlin, Johan Lundqvist, Maria Ellfolk, et al.
European Journal of Clinical Pharmacology
|
June 8, 2021
Second-generation antipsychotic use during pregnancy and risk of congenital malformations
Maria Ellfolk, Maarit K Leinonen, Mika Gissler, et al.
British Journal of Clinical Pharmacology
|
December 12, 2019
Placental transporter-mediated drug interactions and offspring congenital anomalies
Maria Ellfolk, Aleksi Tornio, Mikko Niemi, et al.
European Journal of Clinical Pharmacology
|
November 5, 2019
Second-generation antipsychotics and pregnancy complications
Maria Ellfolk, Maarit K Leinonen, Mika Gissler, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Reproductive Toxicology (Elmsford, N.Y.)
|
May 8, 2010
Risks associated with in utero and lactation exposure to selective serotonin reuptake inhibitors (SSRIs)
Maria Ellfolk, Heli Malm
Duodecim; Laaketieteellinen Aikakauskirja
|
December 1, 2017
Which drugs can be used during pregnancy?
Heli Malm, Maria Ellfolk
Duodecim; Laaketieteellinen Aikakauskirja
|
November 22, 2012
[Poisonings and their treatment during pregnancy]
Maria Ellfolk, Heli Malm
Biochemical and Biophysical Research Communications
|
May 13, 2006
Isolation and properties of the CYP2D25 promoter: transcriptional regulation by vitamin D3 metabolites
Maria Ellfolk, Maria Norlin, Kjell Wikvall
Biochemical and Biophysical Research Communications
|
April 21, 2007
Phenobarbital suppresses vitamin D3 25-hydroxylase expression: a potential new mechanism for drug-induced osteomalacia
Fardin Hosseinpour, Maria Ellfolk, Maria Norlin, et al.
Molecular Pharmacology
|
March 17, 2009
Regulation of human vitamin D(3) 25-hydroxylases in dermal fibroblasts and prostate cancer LNCaP cells
Maria Ellfolk, Maria Norlin, Katarina Gyllensten, et al.
Basic & Clinical Pharmacology & Toxicology
|
July 13, 2016
Drug-Mediated Gene Regulation of Vitamin D<sub>3</sub> Metabolism in Primary Human Dermal Fibroblasts
Maria Norlin, Johan Lundqvist, Maria Ellfolk, et al.
European Journal of Clinical Pharmacology
|
June 8, 2021
Second-generation antipsychotic use during pregnancy and risk of congenital malformations
Maria Ellfolk, Maarit K Leinonen, Mika Gissler, et al.
British Journal of Clinical Pharmacology
|
December 12, 2019
Placental transporter-mediated drug interactions and offspring congenital anomalies
Maria Ellfolk, Aleksi Tornio, Mikko Niemi, et al.
European Journal of Clinical Pharmacology
|
November 5, 2019
Second-generation antipsychotics and pregnancy complications
Maria Ellfolk, Maarit K Leinonen, Mika Gissler, et al.
Page
of 2